Paper29942003
2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK.
Bung N and 11 others. Sci Rep, 2018. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. 2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK. Papers, record 29942003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29942003
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 2-[2-(4-(trifluoromethyl)phenylamino)thiazol-4-yl]acetic acid (Activator-3) is a potent activator of AMPK.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AMP-Activated Protein Kinases | Major topic |
| Acetates | Major topic |
| Thiazoles | Major topic |
| Animals | |
| Brain | |
| Enzyme Activation | |
| Hep G2 Cells | |
| Humans | |
| Molecular Docking Simulation | |
| Protein Domains | |
| Rats |
Source PubMed
References83
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10642499 | The regulation of AMP-activated protein kinase by phosphorylation. | Biochem J | 2000 | https://conductscience.org/library/papers/10642499 | PubMed |
| 2 | 19273282 | Targeting the AMPK pathway for the treatment of Type 2 diabetes. | Front Biosci (Landmark Ed) | 2009 | https://conductscience.org/library/papers/19273282 | PubMed |
| 3 | 11407343 | Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11407343 | PubMed |
| 4 | 1967820 | Regulation of the mevalonate pathway. | Nature | 1990 | https://conductscience.org/library/papers/1967820 | PubMed |
| 5 | 28467931 | Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice. | Cell Metab | 2017 | https://conductscience.org/library/papers/28467931 | PubMed |
| 6 | 17034125 | Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. | J Med Chem | 2006 | https://conductscience.org/library/papers/17034125 | PubMed |
| 7 | 21399626 | Structure of mammalian AMPK and its regulation by ADP. | Nature | 2011 | https://conductscience.org/library/papers/21399626 | PubMed |
| 8 | 20408171 | Improved side-chain torsion potentials for the Amber ff99SB protein force field. | Proteins | 2010 | https://conductscience.org/library/papers/20408171 | PubMed |
| 9 | 25066137 | Structural basis for AMPK activation: natural and synthetic ligands regulate kinase activity from opposite poles by different molecular mechanisms. | Structure | 2014 | https://conductscience.org/library/papers/25066137 | PubMed |
| 10 | 24093679 | AMP is a true physiological regulator of AMP-activated protein kinase by both allosteric activation and enhancing net phosphorylation. | Cell Metab | 2013 | https://conductscience.org/library/papers/24093679 | PubMed |
| 11 | 9208914 | The AMP-activated protein kinase--fuel gauge of the mammalian cell? | Eur J Biochem | 1997 | https://conductscience.org/library/papers/9208914 | PubMed |
| 12 | 26952388 | Structural basis of allosteric and synergistic activation of AMPK by furan-2-phosphonic derivative C2 binding. | Nat Commun | 2016 | https://conductscience.org/library/papers/26952388 | PubMed |
| 13 | 9638572 | Validation of bioanalytical chromatographic methods. | J Pharm Biomed Anal | 1998 | https://conductscience.org/library/papers/9638572 | PubMed |
| 14 | 8626596 | Characterization of AMP-activated protein kinase beta and gamma subunits. Assembly of the heterotrimeric complex in vitro. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8626596 | PubMed |
| 15 | 21769098 | AMP-activated protein kinase: nature's energy sensor. | Nat Chem Biol | 2011 | https://conductscience.org/library/papers/21769098 | PubMed |
| 16 | 7615556 | High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. | J Biol Chem | 1995 | https://conductscience.org/library/papers/7615556 | PubMed |
| 17 | 10818001 | A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. | Science | 2000 | https://conductscience.org/library/papers/10818001 | PubMed |
| 18 | 26468734 | Co-activator binding protein PIMT mediates TNF-α induced insulin resistance in skeletal muscle via the transcriptional down-regulation of MEF2A and GLUT4. | Sci Rep | 2015 | https://conductscience.org/library/papers/26468734 | PubMed |
| 19 | 11748095 | Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. | Circulation | 2001 | https://conductscience.org/library/papers/11748095 | PubMed |
| 20 | 17084593 | Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. | Nutrition | 2007 | https://conductscience.org/library/papers/17084593 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41127193 | The novel synthesis of a condensed triazine via the heterocyclization of an azo derivative and its characterization, radiolabeling and bio-evaluation. | RSC Adv | 2025 | https://conductscience.org/library/papers/41127193 | PubMed |
| 39879193 | Small Molecule Modulators of AMP-Activated Protein Kinase (AMPK) Activity and Their Potential in Cancer Therapy. | J Med Chem | 2025 | https://conductscience.org/library/papers/39879193 | PubMed |
| 36339617 | Adenosine monophosphate activated protein kinase contributes to skeletal muscle health through the control of mitochondrial function. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36339617 | PubMed |
| 36101419 | AMPK and Diseases: State of the Art Regulation by AMPK-Targeting Molecules. | Biology (Basel) | 2022 | https://conductscience.org/library/papers/36101419 | PubMed |
| 35141506 | PHLPP1 promotes neutral lipid accumulation through AMPK/ChREBP-dependent lipid uptake and fatty acid synthesis pathways. | iScience | 2022 | https://conductscience.org/library/papers/35141506 | PubMed |
| 34854271 | The effects of naringenin and naringin on the glucose uptake and AMPK phosphorylation in high glucose treated HepG2 cells. | J Vet Sci | 2021 | https://conductscience.org/library/papers/34854271 | PubMed |
| 34671255 | Evaluation of Biosafety, Antiobesity, and Endothelial Cells Proliferation Potential of Basil Seed Extract Loaded Organic Solid Lipid Nanoparticle. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34671255 | PubMed |
| 30867601 | AMP-activated protein kinase: the current landscape for drug development. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30867601 | PubMed |
Genes31
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29942003
GET https://conductscience.org/api/papers/v1/29942003/references?page=2